BioHub (Private Equity) Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

BioHub (Private Equity) General Information

Description

Operator of a med-tech and bio-tech incubator intended to nurture early to growth-stage companies and accelerate overseas medical innovation. The company offers hands-on incubation and acceleration programs, investment access, and dedicated CDMO infrastructure, enabling med-tech and biotech entrepreneurs and investors to bring pioneering healthcare products to global markets and drive meaningful clinical impact.

Contact Information

Formerly Known As
Wuhan Guanggu Baiqiao International Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building C7
  • Number 858 Gaoxin Avenue, East Lake High-tech Development Zone
  • Wuhan, Hubei 430070
  • China
+86 177
Primary Industry
Private Equity
Corporate Office
  • Building C7
  • Number 858 Gaoxin Avenue, East Lake High-tech Development Zone
  • Wuhan, Hubei 430070
  • China
+86 177

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioHub (Private Equity) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 02-Jun-2016 Completed Generating Revenue
1. Early Stage VC 23-Dec-2015 Completed Generating Revenue
To view BioHub (Private Equity)’s complete valuation and funding history, request access »

BioHub (Private Equity) Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anjie Investment Venture Capital Minority
Longling Capital Venture Capital Minority
To view BioHub (Private Equity)’s complete investors history, request access »

BioHub (Private Equity) Investments (4)

BioHub (Private Equity)’s most recent deal was a Later Stage VC with Silicon Integrated (Wuhan). The deal was made on 18-Aug-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Silicon Integrated (Wuhan) 18-Aug-2025 Later Stage VC General Purpose Semiconductors
Med-Pace 09-Nov-2020 Early Stage VC Therapeutic Devices
JiSiMingZhi 21-Mar-2018 Seed Round Diagnostic Equipment
Tosiri Medical 24-Feb-2017 Secondary Transaction - Private Other Healthcare Technology Systems
To view BioHub (Private Equity)’s complete investments history, request access »

BioHub (Private Equity) FAQs

  • When was BioHub (Private Equity) founded?

    BioHub (Private Equity) was founded in 2011.

  • Where is BioHub (Private Equity) headquartered?

    BioHub (Private Equity) is headquartered in Wuhan, China.

  • What industry is BioHub (Private Equity) in?

    BioHub (Private Equity)’s primary industry is Private Equity.

  • Is BioHub (Private Equity) a private or public company?

    BioHub (Private Equity) is a Private company.

  • What is BioHub (Private Equity)’s current revenue?

    The current revenue for BioHub (Private Equity) is .

  • Who are BioHub (Private Equity)’s investors?

    Anjie Investment and Longling Capital have invested in BioHub (Private Equity).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process